Drawing for ASTROMICS

USPTO serial 98145437

ASTROMICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SHEN, DANIEL HOWE
Law office
TMO LAW OFFICE 128

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ASTROMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter Jensen-Haxel

PO BOX 1353ASHLAND, OR 97520United States

Goods and services

ClassDescriptionStatusFirst use
005Nutraceuticals for use as a dietary supplement; Dietary supplements for human consumption; Pharmaceutical preparations, namely, anti-aging treatments; Pharmaceutical preparations, namely, treatments for gene expression reversal and normalization; Pharmaceutical preparations, namely, medications and treatments for low gravity and space-induced illness; Pharmaceutical preparations for the prevention and treatment of low gravity and micro gravity induced illness and related conditions; Pharmaceutical preparations for the prevention and treatment of cellular senescence, fibrosis, inflammation, cytokine production, immunosenescence, cytoskeleton, oxidative stress, and mitochondrial dysfunctionACTIVE—
041Arranging and conducting of seminars and workshops in the field of space travel, manned spaceflight, and low gravity and micro gravity exposure; Arranging and conducting of seminars and workshops in the field of aging, accelerated aging, and simulated aging; Providing information related to space travel, manned spaceflight, and low gravity and micro gravity exposure; Providing information related to aging, accelerated aging, and simulated agingACTIVE—
042Pharmaceutical drug development services; Scientific research; Biological research; Biotechnology research; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development in the pharmaceutical and biotechnology fields; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consulting services in the field of pharmaceutical research Testing, inspection, research, or development of pharmaceutical preparations for gene therapy treatment of low gravity and micro gravity induced illness and related conditions; Laboratory analysis in the field of aging, low gravity exposure, cellular senescence, fibrosis, inflammation, cytokine production, immunosenescence, cytoskeleton, oxidative stress, and mitochondrial dysfunctionACTIVE—
044Providing healthcare and medical information; Pharmaceutical compounding services; Technical consulting in the field of pharmaceutical studies; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of diagnostic medical testing and nutrition; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing in the field of aging, low gravity exposure, cellular senescence, fibrosis, inflammation, cytokine production, immunosenescence, cytoskeleton, oxidative stress, and mitochondrial dysfunctionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Dec 10, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 10, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 29, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 29, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 2, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 2, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 2, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2024DOCKASSIGNED TO EXAMINER—
Sep 22, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 25, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance